Blood Pressure News and Research

RSS

Blood Pressure is the force of circulating blood on the walls of the arteries. Blood pressure is taken using two measurements: systolic (measured when the heart beats, when blood pressure is at its highest) and diastolic (measured between heart beats, when blood pressure is at its lowest). Blood pressure is written with the systolic blood pressure first, followed by the diastolic blood pressure (for example 120/80).

Severe maternal morbidities highly linked to pregnant woman's risk of death

The number of severe maternal morbidities (SMM) a pregnant woman has is highly linked to her risk of maternal death, according to a new study by researchers at ICES and St. Michael's Hospital.

9 Nov 2018

New study does not support hypertensive effect from urate elevation

A study from a group of Massachusetts General Hospital investigators may reduce the concern that elevating levels of urate, an approach being investigated to treat several neurodegenerative disorders, could increase the risk of hypertension.

8 Nov 2018

Female smokers at greater risk of heart attacks, finds study

According to a large population study from the United Kingdom, women who smoke or those who have high blood pressure or diabetes are at a greater risk of heart attacks than men with same risks. The study results were published in the latest issue of the journal British Medical Journal.

8 Nov 2018

Blue light exposure decreases blood pressure

Exposure to blue light decreases blood pressure, reducing the risk of developing cardiovascular disease, a new study from the University of Surrey and Heinrich Heine University Dusseldorf in collaboration with Philips reports.

8 Nov 2018

Study could provide novel treatment strategy for potentially blinding problem

An enzyme known to help our liver get rid of ammonia also appears to be good at protecting our retina, scientists report.

8 Nov 2018

Meat tax would raise prices but save thousands say researchers

Several studies have shown red meat to be harmful in the long run when consumed regularly. Researchers have proposed that a meat tax could deter people from excessive red meat consumption due to raised prices and this could prevent around 6000 deaths annually in UK.

8 Nov 2018

Predictive model could improve sepsis care

Researchers from MIT and Massachusetts General Hospital have developed a predictive model that could guide clinicians in deciding when to give potentially life-saving drugs to patients being treated for sepsis in the emergency room.

7 Nov 2018

Comorbidity negatively impacts quality of life in people with dementia

Most people living with dementia also have at least one other health condition, and health services need to adapt to optimize their health and quality of life, a new study concludes.

7 Nov 2018

Children with poor aerobic fitness have increased risk of type 2 diabetes, cardiovascular disease

Risk factors of type 2 diabetes and cardiovascular disease accumulate in children who have poor aerobic fitness, a new study from the University of Eastern Finland shows.

7 Nov 2018

Fish-rich and vegetarian diet may reduce hypertension-related heart disease symptoms

Elevated levels of trimethylamine N-oxide--a compound linked with the consumption of fish, seafood and a primarily vegetarian diet--may reduce hypertension-related heart disease symptoms.

7 Nov 2018

Energy drinks narrow blood vessels within 90 minutes of intake

Researchers have found that within one and half hour of taking an energy drink the internal diameter of the blood vessels is reduced by half on an average. As the blood vessels narrow, the vital blood supply to the organs also reduces and this can lead to several problems – heart attacks and strokes being just two of them.

5 Nov 2018

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved LORBRENA, a third-generation anaplastic lymphoma kinase tyrosine kinase inhibitor for patients with ALK-positive metastatic non-small cell lung cancer whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease; or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

5 Nov 2018